BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16327028)

  • 1. Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids.
    Marschall HU; Wagner M; Bodin K; Zollner G; Fickert P; Gumhold J; Silbert D; Fuchsbichler A; Sjövall J; Trauner M
    J Lipid Res; 2006 Mar; 47(3):582-92. PubMed ID: 16327028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
    Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity.
    Kitada H; Miyata M; Nakamura T; Tozawa A; Honma W; Shimada M; Nagata K; Sinal CJ; Guo GL; Gonzalez FJ; Yamazoe Y
    J Biol Chem; 2003 May; 278(20):17838-44. PubMed ID: 12637555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice.
    Wagner M; Fickert P; Zollner G; Fuchsbichler A; Silbert D; Tsybrovskyy O; Zatloukal K; Guo GL; Schuetz JD; Gonzalez FJ; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2003 Sep; 125(3):825-38. PubMed ID: 12949728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
    Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene.
    Gnerre C; Blättler S; Kaufmann MR; Looser R; Meyer UA
    Pharmacogenetics; 2004 Oct; 14(10):635-45. PubMed ID: 15454728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
    Cui YJ; Aleksunes LM; Tanaka Y; Goedken MJ; Klaassen CD
    Toxicol Sci; 2009 Jul; 110(1):47-60. PubMed ID: 19407337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.
    Hrycay E; Forrest D; Liu L; Wang R; Tai J; Deo A; Ling V; Bandiera S
    Mol Cell Biochem; 2014 Apr; 389(1-2):119-32. PubMed ID: 24399466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
    Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
    J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice.
    Feng H; Hu Y; Zhou S; Lu Y
    J Appl Toxicol; 2022 Aug; 42(8):1323-1336. PubMed ID: 35128688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of the bile acid pool upregulates cholesterol 7alpha-hydroxylase by deactivating FXR in rabbits.
    Xu G; Pan LX; Erickson SK; Forman BM; Shneider BL; Ananthanarayanan M; Li X; Shefer S; Balasubramanian N; Ma L; Asaoka H; Lear SR; Nguyen LB; Dussault I; Suchy FJ; Tint GS; Salen G
    J Lipid Res; 2002 Jan; 43(1):45-50. PubMed ID: 11792721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.
    Kok T; Hulzebos CV; Wolters H; Havinga R; Agellon LB; Stellaard F; Shan B; Schwarz M; Kuipers F
    J Biol Chem; 2003 Oct; 278(43):41930-7. PubMed ID: 12917447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice.
    Chen P; Li D; Chen Y; Sun J; Fu K; Guan L; Zhang H; Jiang Y; Li X; Zeng X; Chen X; Huang M; Bi H
    Br J Pharmacol; 2017 Dec; 174(23):4345-4361. PubMed ID: 28910492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
    Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
    J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
    Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
    Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.
    Miyata M; Tozawa A; Otsuka H; Nakamura T; Nagata K; Gonzalez FJ; Yamazoe Y
    J Pharmacol Exp Ther; 2005 Feb; 312(2):759-66. PubMed ID: 15466244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge.
    Cho JY; Matsubara T; Kang DW; Ahn SH; Krausz KW; Idle JR; Luecke H; Gonzalez FJ
    J Lipid Res; 2010 May; 51(5):1063-74. PubMed ID: 19965603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.
    Urizar NL; Dowhan DH; Moore DD
    J Biol Chem; 2000 Dec; 275(50):39313-7. PubMed ID: 10998425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.